This paper discusses positive therapeutic gains made with veterans whose primary treatment for posttraumatic stress disorder (PTSD) was artifact corrected neurofeedback. Assessments completed after both 20 and 40 halfhour sessions of treatment identified significant improvements for both auditory and visual attention using the IVA-2 and significant improvements in well-being based on the General Well-Being Scale (GWBS). It was discovered that neurofeedback impacted individuals' overall auditory attention and IVA-2 global auditory test scores significantly improved after both 20 (p < .007, Cohen's d = 0.5) and 40 training sessions (p < .0001, Cohen's d = 0.8). Veterans were found to have significant enhancements in auditory vigilance (p < .03), processing speed (p < .0009) and focus (p < .01). The IVA-2 global measure of visual attention was also found to show significant improvements after 20 sessions (p < .004, Cohen's d = 0.5) and after 40 sessions (p < .06, Cohen's d = 0.4). Specific improvements in visual processing speed (p < .04) and focus (p < .02) were identified after 40 sessions. Ratings of well-being significantly improved after treatment (p < .001, Cohen's d = 0.8) with 84% of the veterans improving five points or more on the GWBS. Improvements in well-being were found to be significantly correlated with increases in veterans' overall auditory attention (r = .44, p < .03) and auditory processing speed (r = .57, p < .005).
The purpose of this study was to examine associations between substance use disclosure during the clinical interview and on the Minnesota Multiphasic Personality Inventory-2-Restructured Form (MMPI-2-RF) Substance Abuse Scale (SUB) among forensic inpatients. Of the 223 archival reports reviewed that had MMPI-2-RF data, 69% of the MMPI-2-RF protocols were valid based on standard validity criteria, resulting in a final sample of 154 patients (98 men, 56 women). We found that patients who endorsed alcohol or marijuana use during the clinical interview often concurrently denied substance use on the MMPI-2-RF SUB scale (the opposite was found for prescription drug abuse). We also found that the MMPI-2-RF SUB scale and other MMPI-2-RF externalizing scales were meaningfully associated with concurrent substance use variables from a record review form. Finally, we found that the MMPI-2-RF SUB scale demonstrated incremental validity over other MMPI-2-RF externalizing scales in the prediction of substance use problems. These results highlight the utility of SUB scale and other self-report instruments in assessing substance use problems. Public Significance StatementThis study evaluated the level of agreement between self-reported substance abuse history in a clinical interview and on a commonly used psychological test among forensic psychiatric inpatients. Results indicated that both methods of self-report provide unique information, indicating that a multimethod approach to clinical data collection regarding substance use information is indicated.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.